254 related articles for article (PubMed ID: 30825616)
41. Anti-proliferative and pro-apoptotic effects of 3,3'-diindolylmethane in human cervical cancer cells.
Zhu J; Li Y; Guan C; Chen Z
Oncol Rep; 2012 Sep; 28(3):1063-8. PubMed ID: 22736073
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
[TBL] [Abstract][Full Text] [Related]
43. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
[TBL] [Abstract][Full Text] [Related]
44. Cyclin-dependent kinase inhibitors, roscovitine and purvalanol, induce apoptosis and autophagy related to unfolded protein response in HeLa cervical cancer cells.
Ozfiliz-Kilbas P; Sarikaya B; Obakan-Yerlikaya P; Coker-Gurkan A; Arisan ED; Temizci B; Palavan-Unsal N
Mol Biol Rep; 2018 Oct; 45(5):815-828. PubMed ID: 29978381
[TBL] [Abstract][Full Text] [Related]
45. The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells.
Brünner-Kubath C; Shabbir W; Saferding V; Wagner R; Singer CF; Valent P; Berger W; Marian B; Zielinski CC; Grusch M; Grunt TW
Breast Cancer Res Treat; 2011 Sep; 129(2):387-400. PubMed ID: 21046231
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
[TBL] [Abstract][Full Text] [Related]
47. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
[TBL] [Abstract][Full Text] [Related]
49. Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells.
Meira DD; de Almeida VH; Mororó JS; Nóbrega I; Bardella L; Silva RL; Albano RM; Ferreira CG
Br J Cancer; 2009 Sep; 101(5):782-91. PubMed ID: 19654571
[TBL] [Abstract][Full Text] [Related]
50. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
[TBL] [Abstract][Full Text] [Related]
51. Abrus Agglutinin, a type II ribosome inactivating protein inhibits Akt/PH domain to induce endoplasmic reticulum stress mediated autophagy-dependent cell death.
Panda PK; Behera B; Meher BR; Das DN; Mukhopadhyay S; Sinha N; Naik PP; Roy B; Das J; Paul S; Maiti TK; Agarwal R; Bhutia SK
Mol Carcinog; 2017 Feb; 56(2):389-401. PubMed ID: 27182794
[TBL] [Abstract][Full Text] [Related]
52. Induction of apoptosis in cervical cancer cells by the duplex drug 5-FdU-ECyd, coupling 2'-deoxy-5-fluorouridine and 3'-C-ethinylcytidine.
Schott S; Brüning A
Gynecol Oncol; 2014 Nov; 135(2):342-8. PubMed ID: 25178996
[TBL] [Abstract][Full Text] [Related]
53. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro.
Lo YL; Wang W
Chem Biol Interact; 2013 Oct; 205(3):188-97. PubMed ID: 23867903
[TBL] [Abstract][Full Text] [Related]
54. Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway.
Li H; Lu Y; Pang Y; Li M; Cheng X; Chen J
Biomed Pharmacother; 2017 Feb; 86():324-333. PubMed ID: 28011380
[TBL] [Abstract][Full Text] [Related]
55. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
56. Discovery of an EGFR tyrosine kinase inhibitor from Ilex latifolia in breast cancer therapy.
Wang C; Wang R; Chen Y; Wang L; Zhou S; Wang H
Bioorg Med Chem Lett; 2019 Jun; 29(11):1282-1290. PubMed ID: 30962086
[TBL] [Abstract][Full Text] [Related]
57. Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer.
Donev IS; Wang W; Yamada T; Li Q; Takeuchi S; Matsumoto K; Yamori T; Nishioka Y; Sone S; Yano S
Clin Cancer Res; 2011 Apr; 17(8):2260-9. PubMed ID: 21220474
[TBL] [Abstract][Full Text] [Related]
58. Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis.
You BR; Moon HJ; Han YH; Park WH
Food Chem Toxicol; 2010 May; 48(5):1334-40. PubMed ID: 20197077
[TBL] [Abstract][Full Text] [Related]
59. The marine-derived pachycladin diterpenoids as novel inhibitors of wild-type and mutant EGFR.
Mohyeldin MM; Akl MR; Siddique AB; Hassan HM; El Sayed KA
Biochem Pharmacol; 2017 Feb; 126():51-68. PubMed ID: 27940262
[TBL] [Abstract][Full Text] [Related]
60. Protodioscin Induces Apoptosis Through ROS-Mediated Endoplasmic Reticulum Stress via the JNK/p38 Activation Pathways in Human Cervical Cancer Cells.
Lin CL; Lee CH; Chen CM; Cheng CW; Chen PN; Ying TH; Hsieh YH
Cell Physiol Biochem; 2018; 46(1):322-334. PubMed ID: 29590661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
